库欣病患者术后启动血栓预防(PIT-CD):一项随机对照试验
该试验为研究者发起的多中心前瞻性随机开放标签盲法终点评估研究,计划纳入206例接受经蝶手术的库欣病患者,按1:1随机分为药物联合机械血栓预防组与单纯机械血栓预防组,主要结局为术后12周内静脉血栓栓塞症风险,旨在评估联合方案的有效性与安全性。
要点
- 库欣病患者术后静脉血栓栓塞症风险显著,是否常规药物预防尚缺乏强证据。
- 试验计划纳入206例经蝶手术的库欣病患者,1:1随机分组。
- 主要结局为术后12周内静脉血栓栓塞症风险。
核心结论
- 该试验旨在评估药物联合机械血栓预防对比单纯机械血栓预防在库欣病患者术后降低静脉血栓栓塞症的有效性与安全性。
研究设计与样本
- 研究者发起的多中心、前瞻性、随机、开放标签、盲法终点评估试验。
- 计划纳入206例诊断为库欣病并接受经蝶手术的患者,按1:1比例随机分组。
主要发现
- 干预组接受药物联合机械血栓预防,对照组仅接受机械血栓预防。
- 主要结局为术后12周内静脉血栓栓塞症的风险。
关键数值与推荐
- 主要结局指标为术后12周内静脉血栓栓塞症风险。
- 随机分组比例为1:1。
- 试验注册号ClinicalTrials.gov NCT04486859,首次注册日期为2020年7月22日。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pituitary surgical intervention remains the preferred treatment for Cushing's disease (CD) while postoperative venous thromboembolism (VTE) is a significant risk. Whether to prescribe pharmacological thromboprophylaxis presents a clinical dilemma, balancing the benefit of reducing VTE risk with the potential for increasing hemorrhagic events in these patients. Currently, strong evidence and established protocols for routine pharmacological thromboprophylaxis in this population are lacking. Therefore, a randomized, controlled trial is warranted to determine the efficacy and safety of combined pharmacological and mechanical thromboprophylaxis in reducing postoperative VTE risk in patients with CD. METHODS: This investigator-initiated, multi-center, prospective, randomized, open-label trial with blinded outcome assessment aims to evaluate the efficacy and safety of combined pharmacological and mechanical thromboprophylaxis compared to mechanical thromboprophylaxis alone in postoperative patients with CD. A total of 206 patients diagnosed with CD who will be undergoing transsphenoidal surgery will be randomized in a 1:1 ratio to receive either combined pharmacological and mechanical thromboprophylaxis (intervention) or mechanical thromboprophylaxis only (control). The primary outcome is the risk of VTE within 12 weeks following surgery. DISCUSSION: This trial represents a significant milestone in evaluating the efficacy of combined pharmacological and mechanical prophylaxis in reducing VTE events in postoperative CD patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04486859, first registered on 22 July 2020.
引用
- Qiao N, He M, Ye Z, et al. Postoperative Initiation of Thromboprophylaxis in patients with Cushing's Disease (PIT-CD): a randomized controlled trial. Trials. 2025. PMID: 40544300. doi:10.1186/s13063-025-08923-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。